Bernabé I. Bustos

904 total citations
20 papers, 364 citations indexed

About

Bernabé I. Bustos is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Bernabé I. Bustos has authored 20 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Physiology. Recurrent topics in Bernabé I. Bustos's work include Parkinson's Disease Mechanisms and Treatments (6 papers), RNA regulation and disease (5 papers) and Alzheimer's disease research and treatments (4 papers). Bernabé I. Bustos is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), RNA regulation and disease (5 papers) and Alzheimer's disease research and treatments (4 papers). Bernabé I. Bustos collaborates with scholars based in United States, Chile and Italy. Bernabé I. Bustos's co-authors include G. Ferrari, Eduardo Pérez‐Palma, Miguel E. Ávila, Marcelo Alarcón, Steven Lubbe, Giorgia D. Ugarte, Dimitri Krainc, Carlos Opazo, Ariel E. Reyes and Evangelos Kiskinis and has published in prestigious journals such as Science, Neuron and PLoS ONE.

In The Last Decade

Bernabé I. Bustos

19 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernabé I. Bustos United States 10 232 102 100 85 57 20 364
Stefano Cattaneo Italy 10 203 0.9× 122 1.2× 97 1.0× 90 1.1× 70 1.2× 18 401
Jussara Mendonça dos Santos Brazil 13 191 0.8× 70 0.7× 173 1.7× 48 0.6× 102 1.8× 24 365
Konrad J. Dębski Poland 10 287 1.2× 83 0.8× 55 0.6× 85 1.0× 39 0.7× 17 523
Olena Korvatska United States 8 133 0.6× 102 1.0× 85 0.8× 70 0.8× 45 0.8× 11 398
Zhenlong Guan China 8 136 0.6× 39 0.4× 59 0.6× 48 0.6× 59 1.0× 14 274
Hannah C. Saternos United States 8 145 0.6× 38 0.4× 65 0.7× 125 1.5× 22 0.4× 12 325
Anne E. Harasta Australia 7 161 0.7× 54 0.5× 88 0.9× 115 1.4× 21 0.4× 8 337
Inês S. Amorim United Kingdom 9 183 0.8× 87 0.9× 35 0.3× 79 0.9× 18 0.3× 12 307
Talia A. Atkin United States 8 348 1.5× 62 0.6× 60 0.6× 167 2.0× 31 0.5× 8 481
Suzanne Granhøj Lindquist Denmark 10 140 0.6× 157 1.5× 56 0.6× 109 1.3× 136 2.4× 16 335

Countries citing papers authored by Bernabé I. Bustos

Since Specialization
Citations

This map shows the geographic impact of Bernabé I. Bustos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernabé I. Bustos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernabé I. Bustos more than expected).

Fields of papers citing papers by Bernabé I. Bustos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernabé I. Bustos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernabé I. Bustos. The network helps show where Bernabé I. Bustos may publish in the future.

Co-authorship network of co-authors of Bernabé I. Bustos

This figure shows the co-authorship network connecting the top 25 collaborators of Bernabé I. Bustos. A scholar is included among the top collaborators of Bernabé I. Bustos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernabé I. Bustos. Bernabé I. Bustos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanson, Barbara A., Xin Dang, Pouya Jamshidi, et al.. (2025). Human pegivirus alters brain and blood immune and transcriptomic profiles of patients with Parkinson’s disease. JCI Insight. 10(13). 2 indexed citations
2.
Sadleir, Katherine R., A. Edwards, Alpesh Patel, et al.. (2025). Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer’s disease model mice. Acta Neuropathologica. 149(1). 51–51. 1 indexed citations
3.
Minakaki, Georgia, Nathaniel Safren, Bernabé I. Bustos, et al.. (2025). Commander complex regulates lysosomal function and is implicated in Parkinson’s disease risk. Science. 388(6743). 204–211. 2 indexed citations
4.
5.
Bustos, Bernabé I., Sara Bandrés‐Ciga, Thiago Peixoto Leal, et al.. (2024). Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson’s disease risk. Brain. 148(6). 2060–2074. 1 indexed citations
6.
González-Latapí, Paulina, et al.. (2024). Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease. Annals of Neurology. 95(6). 1162–1172. 6 indexed citations
7.
Belur, Nandkishore R., Bernabé I. Bustos, Steven Lubbe, & Joseph R. Mazzulli. (2024). Nuclear aggregates of NONO/SFPQ and A-to-I-edited RNA in Parkinson’s disease and dementia with Lewy bodies. Neuron. 112(15). 2558–2580.e13. 11 indexed citations
8.
Sarmiento, Ignacio Juan Keller, Bernabé I. Bustos, Joanna Blackburn, et al.. (2024). De novo FRMD5 Missense Variants in Patients with Childhood‐Onset Ataxia, Prominent Nystagmus, and Seizures. Movement Disorders. 39(7). 1231–1236. 1 indexed citations
9.
Nasca, Alessia, Niccolò E. Mencacci, Federica Invernizzi, et al.. (2023). Variants in ATP5F1B are associated with dominantly inherited dystonia. Brain. 146(7). 2730–2738. 7 indexed citations
10.
Bustos, Bernabé I., Kimberley J. Billingsley, Cornelis Blauwendraat, et al.. (2022). Genome-wide contribution of common short-tandem repeats to Parkinson’s disease genetic risk. Brain. 146(1). 65–74. 20 indexed citations
11.
Simkin, Dina, Bernabé I. Bustos, Christina M. Ambrosi, et al.. (2022). Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls. Stem Cell Reports. 17(4). 993–1008. 36 indexed citations
12.
Hu, Jing, Cheryl Waters, Dan Spiegelman, et al.. (2022). Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson's disease cohorts of European descent. Neurobiology of Aging. 119. 136–138. 1 indexed citations
13.
Monje, Mariana H.G., et al.. (2022). Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease. Movement Disorders. 38(2). 185–195. 17 indexed citations
14.
Simkin, Dina, Carlos G. Vanoye, Reshma R. Desai, et al.. (2021). Dyshomeostatic modulation of Ca2+-activated K+ channels in a human neuronal model of KCNQ2 encephalopathy. eLife. 10. 26 indexed citations
15.
Lubbe, Steven, Bernabé I. Bustos, Jing Hu, et al.. (2021). Assessing the relationship between monoallelic PRKN mutations and Parkinson’s risk. Human Molecular Genetics. 30(1). 78–86. 37 indexed citations
16.
Bustos, Bernabé I., Sara Bandrés‐Ciga, J. Raphael Gibbs, et al.. (2020). Replication assessment of NUS1 variants in Parkinson's disease. Neurobiology of Aging. 101. 300.e1–300.e3. 7 indexed citations
17.
Pérez‐Palma, Eduardo, Víctor Andrade, Bernabé I. Bustos, et al.. (2016). Early Transcriptional Changes Induced by Wnt/β-Catenin Signaling in Hippocampal Neurons. Neural Plasticity. 2016. 1–13. 18 indexed citations
18.
Pérez‐Palma, Eduardo, Bernabé I. Bustos, Marcelo Alarcón, et al.. (2014). Overrepresentation of Glutamate Signaling in Alzheimer's Disease: Network-Based Pathway Enrichment Using Meta-Analysis of Genome-Wide Association Studies. PLoS ONE. 9(4). e95413–e95413. 48 indexed citations
19.
Ferrari, G., et al.. (2014). Wnt/β-Catenin Signaling in Alzheimer’s Disease. CNS & Neurological Disorders - Drug Targets. 13(5). 745–754. 80 indexed citations
20.
Alarcón, Marcelo, Qubai Hu, Miguel E. Ávila, et al.. (2012). A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer's disease. Neurobiology of Aging. 34(6). 1709.e9–1709.e18. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Cattaneo Breakdown of academic impact, for papers by Jussara Mendonça dos Santos Breakdown of academic impact, for papers by Konrad J. Dębski Breakdown of academic impact, for papers by Olena Korvatska Breakdown of academic impact, for papers by Zhenlong Guan Breakdown of academic impact, for papers by Hannah C. Saternos Breakdown of academic impact, for papers by Anne E. Harasta Breakdown of academic impact, for papers by Inês S. Amorim Breakdown of academic impact, for papers by Talia A. Atkin Breakdown of academic impact, for papers by Suzanne Granhøj Lindquist
Rankless by CCL
2026